v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net revenues $ 9,131,317 $ 11,713,055
Costs and expenses:    
Cost of products sold 1,933,889 1,425,714
Selling and marketing 5,064,875 4,231,980
Research and development 1,458,436 1,295,076
General and administrative 2,554,475 2,463,008
Amortization 1,248,934 1,005,330
Total costs and expenses 12,260,609 10,421,108
Operating income (loss) (3,129,292) 1,291,947
Interest income 78,031 125,709
Interest expense (85,839) (163,802)
Income (loss) before income taxes (3,137,100) 1,253,854
Income tax expense (3,871) (5,670)
Co-commercialization investment loss (146,080) 0
Net income (loss) (3,287,051) 1,248,184
Net loss (income) at subsidiary attributable to noncontrolling interests (2,588) 8,884
Net income (loss) attributable to common shareholders $ (3,289,639) $ 1,257,068
Income (loss) per share attributable to common shareholders    
Basic (in USD per share) $ (0.22) $ 0.08
Diluted (in USD per share) $ (0.22) $ 0.08
Weighted-average shares outstanding    
Basic (in shares) 14,960,210 14,942,522
Diluted (in shares) 14,960,210 15,259,824